Interestingly, 48h of HE treatment counteracted these effects, significantly reducing COL1A2, α-SMA, MMP-2 and VIM protein expression, with detectable effects at 50 μg/mL, and more pronounced inhibition observed at 75 μg/mL. Here, ACTA1 is linked to hereditary elliptocytosis.